Methylenedianiline

This website is not the official or final authority to determine OSHA compliance responsibilities, which are set forth in OSHA standards themselves, and the Occupational Safety and Health Act of 1970. Because OSHA regulations are constantly being added, deleted, and/or revised, you must not rely on this website as the official or final authority of OSHA training requirements; refer to the official OSHA regulations available on OSHA’s website (osha.gov).  –  See disclaimers.

1910.1050 – Methylenedianiline

(d)(1)(iii) – The plan shall specifically include provisions for alerting and evacuating affected employees as well as the elements prescribed in 29 CFR 1910.38 and 29 CFR 1910.39, “Emergency action plans” and “Fire prevention plans,” respectively.

(e)(7)(i) – The employer shall, within 15 working days after the receipt of the results of any monitoring performed under this standard, notify each employee of these results, in writing, either individually or by posting of results in an appropriate location that is accessible to affected employees.

(h)(2) – Respirator program. The employer must implement a respiratory protection program in accordance with § 1910.134 (b) through (d) (except (d)(1)(iii)), and (f) through (m), which covers each respirator.

(i)(3) – Cleaning and replacement.

(iv) Any employer who gives MDA-contaminated clothing to another person for laundering shall inform such person of the requirement to prevent the release of MDA.

(v) The employer shall inform any person who launders or cleans protective clothing or equipment contaminated with MDA of the potentially harmful effects of exposure.

(k)(3) – Information and training.

(i) The employer shall provide employees with information and training on MDA, in accordance with 29 CFR 1910.1200(h), at the time of initial assignment and at least annually thereafter.

(ii) In addition to the information required under 29 CFR 1910.1200, the employer shall:

(A) – Provide an explanation of the contents of this section, including appendices A and B, and indicate to employees where a copy of the standard is available;

(B) – Describe the medical surveillance program required under paragraph (m) of this section, and explain the information contained in Appendix C; and

(C) – Describe the medical removal provision required under paragraph (m) of this section.

(4) – Access to training materials.

(i) – The employer shall make readily available to all affected employees, without cost, all written materials relating to the employee training program, including a copy of this regulation.

(o)(1) – Employee observation. The employer shall provide affected employees, or their designated representatives, an opportunity to observe the measuring or monitoring of employee exposure to MDA conducted pursuant to paragraph (e) of this section.